Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2020-10-21 | 2020-11-28 | 126771 |
| APO-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-04-16 | 2021-04-26 | 137595 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2021-06-11 | 2021-06-28 | 140782 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-13 | 158367 |
| APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2023-09-01 | 2023-10-20 | 203560 |
| APO-PREGABALIN | 150MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216726 |
| APO-PREGABALIN | 225MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216729 |
| APO-PREGABALIN | 25MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216732 |
| APO-PREGABALIN | 300MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216735 |
| APO-PREGABALIN | 50MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216738 |
| APO-PREGABALIN | 75MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216741 |
| APO-PROCAINAMIDE CAP 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18976 |
| APO-PROCAINAMIDE CAP 375MG | 375G | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18979 |
| APO-PROCAINAMIDE CAP 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18982 |
| APO-PROPAFENONE | 300MG | TABLET | Resolved | 2017-03-11 | 2018-08-30 | 460 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-05-04 | 2017-07-13 | 8880 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-04 | 2017-10-27 | 20885 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-27 | 2018-08-30 | 23632 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-05-08 | 2020-06-08 | 114318 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124356 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |